Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1984 2
1985 1
1989 2
1990 1
2000 1
2002 2
2003 2
2004 1
2005 1
2006 1
2008 1
2009 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Treatment of stage II endometrial carcinoma.
Boothby RA, Carlson JA, Neiman W, Rubin MM, Morgan MA, Schultz D, Mikuta JJ. Boothby RA, et al. Gynecol Oncol. 1989 May;33(2):204-8. doi: 10.1016/0090-8258(89)90553-2. Gynecol Oncol. 1989. PMID: 2495242 Free article.
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group.
Bookman MA, Darcy KM, Clarke-Pearson D, Boothby RA, Horowitz IR. Bookman MA, et al. Among authors: boothby ra. J Clin Oncol. 2003 Jan 15;21(2):283-90. doi: 10.1200/JCO.2003.10.104. J Clin Oncol. 2003. PMID: 12525520 Clinical Trial.
17 results